• Delek US Holdings, Inc. reported first-quarter 2026 results with sales of US$2,653.1 million and a net loss of US$201.3 million, while also affirming a US$0.255 quarterly dividend and appointing Amber Russell as Executive Vice President, Refining to oversee its refining operations.
• Despite the loss widening, the timely, on-budget completion of the Big Spring refinery turnaround and progress on the Enterprise Optimization Plan underscored management’s focus on improving operational reliability, cash flow, and capital returns.
• Now we’ll examine how the Big Spring turnaround completion and operational gains may influence Delek US Holdings’ broader investment narrative.

This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.

Delek US Holdings Investment Narrative Recap

To own Delek US Holdings, you need to believe that improving refinery execution and the Enterprise Optimization Plan can eventually turn persistent losses into healthier cash generation, despite exposure to hydrocarbons and regulatory uncertainty. The latest quarter’s wider net loss, alongside the on time, on budget Big Spring turnaround, does not materially change the near term balance between the key catalyst of EOP delivery and the major risk around refining focused cash flow strain.

Among the recent announcements, the appointment of Amber Russell as Executive Vice President, Refining stands out alongside the Big Spring turnaround. With almost three decades in global downstream operations, her role directly connects to Delek’s most important catalyst: lifting refinery reliability and product yields to support the Enterprise Optimization Plan, while trying to manage the ongoing risk that continued net losses and capital spending could pressure free cash flow and limit financial flexibility.

Yet behind the operational progress, investors should still watch the unresolved exposure to small refinery exemptions and potential regulatory outcomes that could...

Delek US Holdings' narrative projects $11.8 billion revenue and $166.1 million earnings by 2029.

Uncover how Delek US Holdings' forecasts yield a $49.38 fair value, a 6% upside to its current price.

Exploring Other Perspectives

Before this update, the most optimistic analysts were assuming revenue could reach about US$14.0 billion and earnings around US$512.7 million, while also counting on a very favorable small refinery exemption outcome. If you lean bullish, that is a much more optimistic story than consensus, and this quarter’s results may prompt you to revisit how realistic those assumptions still feel.

Explore 4 other fair value estimates on Delek US Holdings - why the stock might be worth just $49.38!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Delek US Holdings research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Delek US Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Delek US Holdings' overall financial health at a glance.

Curious About Other Options?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Find 49 companies with promising cash flow potential yet trading below their fair value.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.